ClearPoint Neuro Inc (NASDAQ: CLPT) on Friday, soared 9.17% from the previous trading day, before settling in for the closing price of $19.74. Within the past 52 weeks, CLPT’s price has moved between $9.76 and $21.57.
Annual sales at Healthcare sector company slipped by -10.69% over the past five years. The company achieved an average annual earnings per share of -15.00%. With a float of $24.34 million, this company’s outstanding shares have now reached $28.42 million.
ClearPoint Neuro Inc (CLPT) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of ClearPoint Neuro Inc is 14.39%, while institutional ownership is 33.53%. The most recent insider transaction that took place on Jun 10 ’25, was worth 132,800. In this transaction Director of this company sold 10,000 shares at a rate of $13.28, taking the stock ownership to the 77,381 shares. Before that another transaction happened on Jun 09 ’25, when Company’s CEO and President sold 21,247 for $13.29, making the entire transaction worth $282,373. This insider now owns 243,522 shares in total.
ClearPoint Neuro Inc (CLPT) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.18 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.17) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around -15.00% per share during the next fiscal year.
ClearPoint Neuro Inc (NASDAQ: CLPT) Trading Performance Indicators
ClearPoint Neuro Inc (CLPT) is currently performing well based on its current performance indicators. A quick ratio of 6.45 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of ClearPoint Neuro Inc (CLPT)
ClearPoint Neuro Inc (NASDAQ: CLPT) saw its 5-day average volume 3.79 million, a positive change from its year-to-date volume of 0.41 million. As of the previous 9 days, the stock’s Stochastic %D was 88.75%.
During the past 100 days, ClearPoint Neuro Inc’s (CLPT) raw stochastic average was set at 98.22%, which indicates a significant increase from 98.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.22 in the past 14 days, which was higher than the 0.72 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.43, while its 200-day Moving Average is $13.37. Nevertheless, the first resistance level for the watch stands at $22.59 in the near term. At $23.64, the stock is likely to face the second major resistance level. The third major resistance level sits at $25.52. If the price goes on to break the first support level at $19.67, it is likely to go to the next support level at $17.79. The third support level lies at $16.75 if the price breaches the second support level.
ClearPoint Neuro Inc (NASDAQ: CLPT) Key Stats
Market capitalization of the company is 612.61 million based on 28,427K outstanding shares. Right now, sales total 31,390 K and income totals -18,910 K. The company made 9,220 K in profit during its latest quarter, and -5,840 K in sales during its previous quarter.
